Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sturrock

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Heart Journal|July 1, 1986
Calcium antagonists and the ischaemic myocardiumW G Nayler, W J Sturrock
Journal of Molecular and Cellular Cardiology|April 1, 1984
An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused heartsW G Nayler, W J Sturrock
Journal of Cardiovascular Pharmacology|May 1, 1985
Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusionW G Nayler, W J Sturrock
Clinical and Experimental Pharmacology & Physiology|February 1, 1988
Calcium antagonists and hypertensionW G Nayler, J S Dillon, W J Sturrock
Journal of Cardiovascular Pharmacology|January 1, 1988
Chronic calcium antagonist therapy: some unexpected resultsW G Nayler, W J Sturrock, J S Dillon
Journal of Molecular and Cellular Cardiology|July 1, 1985
The protective effect of prazosin on the ischaemic and reperfused myocardiumW G Nayler, M Gordon, D J Stephens, et al.
The American Journal of Cardiology|January 30, 1987
Fundamental mechanisms of action of calcium antagonists in myocardial ischemiaW G Nayler, S Panagiotopoulos, J S Elz, et al.
Journal of Cardiovascular Pharmacology|December 1, 1988
Effect of chronic verapamil therapy on cardiac norepinephrine and beta-adrenoceptor densityW G Nayler, J S Dillon, W J Sturrock, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Heart Journal|July 1, 1986
Calcium antagonists and the ischaemic myocardiumW G Nayler, W J Sturrock
Journal of Molecular and Cellular Cardiology|April 1, 1984
An inhibitory effect of verapamil and diltiazem on the release of noradrenaline from ischaemic and reperfused heartsW G Nayler, W J Sturrock
Journal of Cardiovascular Pharmacology|May 1, 1985
Inhibitory effect of calcium antagonists on the depletion of cardiac norepinephrine during postischemic reperfusionW G Nayler, W J Sturrock
Clinical and Experimental Pharmacology & Physiology|February 1, 1988
Calcium antagonists and hypertensionW G Nayler, J S Dillon, W J Sturrock
Journal of Cardiovascular Pharmacology|January 1, 1988
Chronic calcium antagonist therapy: some unexpected resultsW G Nayler, W J Sturrock, J S Dillon
Journal of Molecular and Cellular Cardiology|July 1, 1985
The protective effect of prazosin on the ischaemic and reperfused myocardiumW G Nayler, M Gordon, D J Stephens, et al.
The American Journal of Cardiology|January 30, 1987
Fundamental mechanisms of action of calcium antagonists in myocardial ischemiaW G Nayler, S Panagiotopoulos, J S Elz, et al.
Journal of Cardiovascular Pharmacology|December 1, 1988
Effect of chronic verapamil therapy on cardiac norepinephrine and beta-adrenoceptor densityW G Nayler, J S Dillon, W J Sturrock, et al.
Pageof 1